The DOI matches its Crossref record; 199 of the 202 references it cites were found in a registry or an index.
The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects
Abstract
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to fibrosis, and potentially cirrhosis. PBC has been considered a prototypical autoimmune condition, given the presence of specific autoantibodies and the immune response against well-defined mitochondrial autoantigens. Further evidence supports the interaction of immunogenetic and environmental factors in the etiology of PBC. An immunological attack on biliary epithelial cells with secondary failure of biliary transporters, eg, the anion exchange protein 2, is traditionally considered the primum movens. A recent hypothesis proposes a primary failure of biliary epithelial cells with the downregulation of anion exchange protein 2 secondary to epigenetic mechanisms (miR-506 overexpression), which then triggers the immunological storm. This highlights the secretory defect as the culprit and sustaining factor in the pathogenesis of PBC with ursodeoxycholic acid helping to restore this protective mechanism by promoting bicarbonate secretion and reducing bile acid toxicity. In this review, we aim to provide the most recent evidence on the immunopathogenesis of PBC. We will analyze the immune function of the biliary epithelium, assessing the immunomodulatory functions of the bile acids and the evidence of the immunological roles of the secretory pathways targeted by the current treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gene variants in HLA or IL-12 signaling have been associated with PBC, and most patients display autoreactive antibodies against mitochondrial antigens and subsequent failure of biliary transporters, e.g., anion exchange protein 2 (AE2) [177–179].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [179]
Citations
Cites
Bartel, D. P. (2018) · Cell · doi:10.1016/j.cell.2018.03.006 · Cited by 3,751
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Farh, K. K.-H., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., et al. (2015) · Nature · doi:10.1038/nature13835 · Cited by 1,956
Bile acid metabolites control TH17 and Treg cell differentiation
Hang, S., Paik, D., Yao, L., Kim, E., Trinath, J., Lu, J., Ha, S., Nelson, B. N., Kelly, S. P., Wu, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1785-z · Cited by 1,457
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
Song, X., Sun, X., Oh, S. F., Wu, M., Zhang, Y., Zheng, W., Geva-Zatorsky, N., Jupp, R., Mathis, D., Benoist, C., et al. (2020) · Nature · doi:10.1038/s41586-019-1865-0 · Cited by 1,024
Crispe, I. N. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132629 · Cited by 986
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Campbell, C., McKenney, P. T., Konstantinovsky, D., Isaeva, O. I., Schizas, M., Verter, J., Mai, C., Jin, W.-B., Guo, C.-J., Violante, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2193-0 · Cited by 901
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756
The role of peroxisome proliferator-activated receptors (PPAR) in immune responses
Christofides, A., Konstantinidou, E., Jani, C., & Boussiotis, V. A. (2021) · Metabolism · doi:10.1016/j.metabol.2020.154338 · Cited by 720
Gershwin, E. M., Selmi, C., Worman, H. J., Gold, E. B., Watnik, M., Utts, J., Lindor, K. D., Kaplan, M. M., & Vierling, J. M. (2005) · Hepatology · doi:10.1002/hep.20907 · Cited by 621
Research works printed but not linked: 2
- Butler, 1995, Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?, Biochem Mol Biol Int, 35, 473
- Gujral, 2004, Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation, Hepatology, 40, 998
Cited by
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
Massironi, S., Dispinzieri, G., Rossi, A., Cristoferi, L., Lenti, M. V., Gerussi, A., Elvevi, A., Carbone, M., Bonfichi, A., Sabatino, A. D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1628478 · Cited by 9
Qin, X., & Jin, Z. (2025) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-6138 · Cited by 7
Cheng, Y., Chen, J., Jiang, W., Li, W., Wang, Z., Chen, F., Xie, X., & Li, J. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c06961 · Cited by 6
Clinical outcomes and early- prognostic biomarkers of primary biliary cholangitis with ductopenia
Wang, W.-J., Guo, Z. X., Liu, H., Lv, L., Chang, J., Liu, Z., Ye, H., Ding, H., & Han, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1680942 · Cited by 4
Metadata
- Authors
- Ronca, V., Davies, S. P., Oo, Y. H., & Lleo, A.
- Affiliations
- Humanitas University (IT)
- University of Birmingham (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Department of Biomedical Sciences, Humanitas University, Via Rita Levi, Pieve Emanuele, Milan, Italy
- Venue
- Hepatology
- Published
- 2025-01-03
- Volume
- 82
- Issue
- 4
- Pages
- 877-894
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W4406120002
- Cited by
- 22
- References
- 202
- Citations by year
- 2026: 11 · 2025: 11
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- primary biliary cirrhosis, immunopathogenesis, autoantibodies, mitochondrial autoantigens, cholangiocytes, miR-506, epigenetic regulation, bile acid secretion, bicarbonate secretion, bile acid toxicity, ursodeoxycholic acid, immunomodulation, cholestatic liver disease, liver fibrosis
- MeSH terms
- Bile Acids and Salts, Humans, Liver Cirrhosis, Biliary, Ursodeoxycholic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects. https://app.cochat.ai/papers/10.1097/hep.0000000000001225
- The paper
- Ronca, V., Davies, S. P., Oo, Y. H., & Lleo, A. (2025). The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects. Hepatology. https://doi.org/10.1097/hep.0000000000001225
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.